{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:36:13Z","timestamp":1770503773095,"version":"3.49.0"},"reference-count":47,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T00:00:00Z","timestamp":1173744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:p><jats:bold>Objective:\u2002<\/jats:bold> To investigate prolactin levels and related side effects in 128 men and 90 women initially treated with risperidone.<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> Patients initially treated with risperidone were followed over 5\u2003years, during which 45% were switched to other antipsychotic drugs.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Initially, prolactin levels were fivefold the norm in women, and threefold in men. Diagnosis did not affect the prolactin level if adjustment for sex, current age, and age at onset of psychosis was applied. Prolactin levels did not correlate significantly neither with any Positive and Negative Symptom Scale item or subscale, nor with side effects. Drugs other than risperidone were not associated with high prolactin levels. For patients on continuous monotherapy risperidone treatment, there was a marked linear reduction of prolactin level over all 5\u2003years.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Risperidone induces a higher prolactin elevation than other atypical antipsychotics, but the effect adapts over time. Prolactin was not associated with expected side effects (e.g. sexual, mental, or weight gain).<\/jats:p>","DOI":"10.1111\/j.1600-0447.2006.00897.x","type":"journal-article","created":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T08:18:53Z","timestamp":1173773933000},"page":"268-276","source":"Crossref","is-referenced-by-count":44,"title":["Prolactin level during 5\u2003years of risperidone treatment in patients with psychotic disorders"],"prefix":"10.1111","volume":"115","author":[{"given":"J.","family":"Eberhard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Holstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Levander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,13]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.184.4133.177"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.184.4143.1243"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200507000-00001"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199302000-00004"},{"key":"e_1_2_9_6_2","first-page":"213","article-title":"Risperidone: clinical safety and efficacy in schizophrenia","volume":"28","author":"Borison RL","year":"1992","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.166.6.712"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014288"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0149-2918(95)80105-7"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448020-00009"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-198-43286B"},{"key":"e_1_2_9_12_2","first-page":"681","article-title":"The comparative endocrinology of prolactin","volume":"24","author":"Bern HA","year":"1968","journal-title":"Recent Prog Horm Res"},{"issue":"17","key":"e_1_2_9_13_2","first-page":"1","article-title":"Prolactin response to neuroleptics. Clinical and theoretical implications","volume":"17","author":"\u00d6Hman R","year":"1980","journal-title":"J Neural Transm"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/10401230209147453"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.5.1010"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00351-1"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00128-2"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.12.2259"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.1.162"},{"key":"e_1_2_9_20_2","first-page":"1","article-title":"Short and long\u2010term fluctuations in plasma prolactin concentration in normal subjects","volume":"97","author":"Djursing H","year":"1987","journal-title":"Acta Endocrinol"},{"key":"e_1_2_9_21_2","article-title":"Five years follow up during antipsychotic treatment; efficacy, safety, functional and social outcome","author":"Lindstr\u00f6m E","journal-title":"Acta Psychiatr Scand"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1987.tb10566.x"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2006.00899.x"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.133"},{"key":"e_1_2_9_26_2","first-page":"143","article-title":"Antipsychotic induced hyperprolactinemia and sexual dysfunction","volume":"36","author":"Compton MT","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(02)00022-7"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.6.684"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00380979"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(83)90100-1"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.146.3.229"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/6.1.88"},{"key":"e_1_2_9_33_2","article-title":"Clinical decision\u2010making processes in antipsychotic treatment","author":"Levander S","journal-title":"Acta Psychiatr Scand"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427494"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00429003"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(86)90124-1"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00179941"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244140"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426949"},{"key":"e_1_2_9_40_2","first-page":"513","article-title":"Adverse effects of anticholinergic medication on positive schizophrenic symptoms","volume":"13","author":"Johnstone EC","year":"1983","journal-title":"Biol Med"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(81)90078-0"},{"key":"e_1_2_9_42_2","first-page":"151","article-title":"Serum neuroleptic levels, prolactin levels and relapse: a two\u2010year study of schizophrenic outpatients","volume":"48","author":"Faraone SV","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00113-0"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674370104600906"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.133.5.2227"},{"key":"e_1_2_9_46_2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1210\/endo.132.2.8425500","article-title":"Effect of homologous placental lactogens, prolactins, and growth hormones on islet B\u2010cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet functioning during pregnancy","volume":"132","author":"Brelje TC","year":"1993","journal-title":"Endocrinology"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-3448-8_2"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001090050302"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.2006.00897.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.2006.00897.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T12:55:29Z","timestamp":1697374529000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.2006.00897.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,13]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1600-0447.2006.00897.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.2006.00897.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,13]]}}}